software package medcalc (r) Search Results


90
GraphPad Software Inc prism 5.0
Prism 5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc06307720-65-9-17?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
prism 5.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd software package medcalc 17.2
Software Package Medcalc 17.2, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc08373346-94-7-8?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
software package medcalc 17.2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd software package version 12
Software Package Version 12, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc11173123-156-9-12?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
software package version 12 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd package version 16.8.4
Package Version 16.8.4, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc09637171-192-1-3?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
package version 16.8.4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd statistical software package version 14.10.2
Statistical Software Package Version 14.10.2, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc05540630-35-7-12?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
statistical software package version 14.10.2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd package medcalc v9.4.2.0
Package Medcalc V9.4.2.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc03111171-69-5-7?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
package medcalc v9.4.2.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd 12.3.0.0 software package for windows
12.3.0.0 Software Package For Windows, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pm24309383-110-7-6?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
12.3.0.0 software package for windows - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd an easy-to-use statistical software package
An Easy To Use Statistical Software Package, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pm39547298-125-19-24?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
an easy-to-use statistical software package - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd statistical package version 14.12.0
Statistical Package Version 14.12.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc09391795-119-3-8?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
statistical package version 14.12.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd version 17.9.7 statistical software package
Version 17.9.7 Statistical Software Package, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc06684553-60-8-7?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
version 17.9.7 statistical software package - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd software package v. 12
Software Package V. 12, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pm27214119-83-9-9?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
software package v. 12 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd roc curve medcalc software package version 7.3.0.0
<t>(A)</t> <t>Venn</t> diagram analysis was carried out to identify the intersection of phenotypic/functional biomarkers amongst NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11) and select those common attributes between PV(day30-45) and PV(year1-9), considered biomarkers of protection. Detailed Venn Diagram report is provided in the . (B) The performance indicators (cut-off, accuracy, sensitivity-Se and specificity-Sp) for the ten selected common biomarkers (eEfCD4, EMCD4, CMCD19, EMCD8, IFNCD4, IL-5CD8, TNFCD4, IFNCD8, TNFCD8 and IL-5CD4) are provided in the inserted table. (C) Heatmap analysis was carried out to illustrate the profile of phenotypic/functional biomarkers common at PV(day30-45) and PV(year1-9) as well as the mean index calculated considering all 10 phenotypic/functional biomarkers together and demonstrate the proportion (%) of volunteers presenting low (Green), median (Black) or high (Red) YF-Ag/CC index. Histograms were constructed to highlight the frequency of volunteers above the median YF-Ag/CC index (Red Curves). (D) Scatter plot were built to demonstrate the sensitivity (Red Circles) and specificity (Green Circles) of the mean index of 10 phenotypic/functional biomarkers, using the cut-off edge (Mean Index = 1.3) provided by the <t>ROC</t> curve analysis. (E) Memory diagram were constructed using the defined cut-off for phenotypic/functional biomarkers, the memory status was defined for each subject, considering the phenotypic/functional (Mean Index of 10 biomarkers >1.3) and PRNT (>2.9 Log mIU/mL, according to Simões et al., 2012). Column statistics were used to calculate the proportion of subjects displaying distinct status of resultant memory, referred as none, phenotypic/functional biomarkers—P&F, PRNT and both. (F) The resultant memory for the 10 phenotypic/functional biomarkers and PRNT was displayed on bar charts. Significant differences at p<0.05 (Chi-square test) of resultant status amongst study groups were represented by letters “a”, b”, “c” and “d” in comparison to NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11), respectively.
Roc Curve Medcalc Software Package Version 7.3.0.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+medcalc+%28r%29/pmc05991646-72-11-13?v=MedCalc+Software+Ltd
Average 90 stars, based on 1 article reviews
roc curve medcalc software package version 7.3.0.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


(A) Venn diagram analysis was carried out to identify the intersection of phenotypic/functional biomarkers amongst NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11) and select those common attributes between PV(day30-45) and PV(year1-9), considered biomarkers of protection. Detailed Venn Diagram report is provided in the . (B) The performance indicators (cut-off, accuracy, sensitivity-Se and specificity-Sp) for the ten selected common biomarkers (eEfCD4, EMCD4, CMCD19, EMCD8, IFNCD4, IL-5CD8, TNFCD4, IFNCD8, TNFCD8 and IL-5CD4) are provided in the inserted table. (C) Heatmap analysis was carried out to illustrate the profile of phenotypic/functional biomarkers common at PV(day30-45) and PV(year1-9) as well as the mean index calculated considering all 10 phenotypic/functional biomarkers together and demonstrate the proportion (%) of volunteers presenting low (Green), median (Black) or high (Red) YF-Ag/CC index. Histograms were constructed to highlight the frequency of volunteers above the median YF-Ag/CC index (Red Curves). (D) Scatter plot were built to demonstrate the sensitivity (Red Circles) and specificity (Green Circles) of the mean index of 10 phenotypic/functional biomarkers, using the cut-off edge (Mean Index = 1.3) provided by the ROC curve analysis. (E) Memory diagram were constructed using the defined cut-off for phenotypic/functional biomarkers, the memory status was defined for each subject, considering the phenotypic/functional (Mean Index of 10 biomarkers >1.3) and PRNT (>2.9 Log mIU/mL, according to Simões et al., 2012). Column statistics were used to calculate the proportion of subjects displaying distinct status of resultant memory, referred as none, phenotypic/functional biomarkers—P&F, PRNT and both. (F) The resultant memory for the 10 phenotypic/functional biomarkers and PRNT was displayed on bar charts. Significant differences at p<0.05 (Chi-square test) of resultant status amongst study groups were represented by letters “a”, b”, “c” and “d” in comparison to NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11), respectively.

Journal: PLoS Neglected Tropical Diseases

Article Title: Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination

doi: 10.1371/journal.pntd.0006462

Figure Lengend Snippet: (A) Venn diagram analysis was carried out to identify the intersection of phenotypic/functional biomarkers amongst NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11) and select those common attributes between PV(day30-45) and PV(year1-9), considered biomarkers of protection. Detailed Venn Diagram report is provided in the . (B) The performance indicators (cut-off, accuracy, sensitivity-Se and specificity-Sp) for the ten selected common biomarkers (eEfCD4, EMCD4, CMCD19, EMCD8, IFNCD4, IL-5CD8, TNFCD4, IFNCD8, TNFCD8 and IL-5CD4) are provided in the inserted table. (C) Heatmap analysis was carried out to illustrate the profile of phenotypic/functional biomarkers common at PV(day30-45) and PV(year1-9) as well as the mean index calculated considering all 10 phenotypic/functional biomarkers together and demonstrate the proportion (%) of volunteers presenting low (Green), median (Black) or high (Red) YF-Ag/CC index. Histograms were constructed to highlight the frequency of volunteers above the median YF-Ag/CC index (Red Curves). (D) Scatter plot were built to demonstrate the sensitivity (Red Circles) and specificity (Green Circles) of the mean index of 10 phenotypic/functional biomarkers, using the cut-off edge (Mean Index = 1.3) provided by the ROC curve analysis. (E) Memory diagram were constructed using the defined cut-off for phenotypic/functional biomarkers, the memory status was defined for each subject, considering the phenotypic/functional (Mean Index of 10 biomarkers >1.3) and PRNT (>2.9 Log mIU/mL, according to Simões et al., 2012). Column statistics were used to calculate the proportion of subjects displaying distinct status of resultant memory, referred as none, phenotypic/functional biomarkers—P&F, PRNT and both. (F) The resultant memory for the 10 phenotypic/functional biomarkers and PRNT was displayed on bar charts. Significant differences at p<0.05 (Chi-square test) of resultant status amongst study groups were represented by letters “a”, b”, “c” and “d” in comparison to NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11), respectively.

Article Snippet: Additional analysis was carried out employing Venn diagram ( http://bioinformatics.psb.ugent.be/webtools/Venn/ ), ROC curve (MedCalc software package, Version 7.3.0.0), heatmap (R Project for Statistical Computing Version 3.0.1) and decision tree J48 algorithm (present in WEKA software version 3.6.11).

Techniques: Functional Assay, Construct, Comparison

(A) Decision tree analysis was carried out to identify root attributes [Ellipses] for phenotypic/functional (P&F) biomarkers amongst NV(day0)&PV(year10-11) [white rectangle] and PV(day30-45)&PV(year1-9) [black rectangle], considered biomarkers to discriminate unprotected from protected subjects. Leave-one-out-cross-validation analysis (LOOCV) was employed to minimize biased performance estimates by using all data set for decision tree model fitting. EMCD8 and IL-5CD4 were selected as major phenotypic and functional 17DD-YF Memory-related biomarkers, respectively. (B) Heatmaps were built, taking the mean index of the top-two phenotypic/functional biomarkers (EMCD8 & IL-5CD4) and demonstrating the proportion (%) of volunteers ranging from low (White) to high (Gray) YF-Ag/CC index. A scatter plot was constructed to show the sensitivity (Gray Circle) and specificity (White Circle) of the top-two biomarkers, employing the cut-off edge (Mean Index = 1.3) provided by the ROC curve analysis. (C) Resultant memory status was defined for each subject, considering the top-two biomarkers (Mean Index >1.3) and PRNT (>2.9 Log mIU/mL, according to Simões et al., 2012). Column statistics were used to calculate the proportion of subjects displaying differing categories of resultant memory, referred as none, top-two biomarkers—P&F, PRNT and both. (D) Pie charts illustrated the overall resultant memory status within each category, as determined by the top-two biomarkers and PRNT. Significant differences at p<0.05 (Chi-square test) of resultant memory status amongst study groups were represented by letters “a”, b”, “c” and “d” in comparison to NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11), respectively.

Journal: PLoS Neglected Tropical Diseases

Article Title: Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination

doi: 10.1371/journal.pntd.0006462

Figure Lengend Snippet: (A) Decision tree analysis was carried out to identify root attributes [Ellipses] for phenotypic/functional (P&F) biomarkers amongst NV(day0)&PV(year10-11) [white rectangle] and PV(day30-45)&PV(year1-9) [black rectangle], considered biomarkers to discriminate unprotected from protected subjects. Leave-one-out-cross-validation analysis (LOOCV) was employed to minimize biased performance estimates by using all data set for decision tree model fitting. EMCD8 and IL-5CD4 were selected as major phenotypic and functional 17DD-YF Memory-related biomarkers, respectively. (B) Heatmaps were built, taking the mean index of the top-two phenotypic/functional biomarkers (EMCD8 & IL-5CD4) and demonstrating the proportion (%) of volunteers ranging from low (White) to high (Gray) YF-Ag/CC index. A scatter plot was constructed to show the sensitivity (Gray Circle) and specificity (White Circle) of the top-two biomarkers, employing the cut-off edge (Mean Index = 1.3) provided by the ROC curve analysis. (C) Resultant memory status was defined for each subject, considering the top-two biomarkers (Mean Index >1.3) and PRNT (>2.9 Log mIU/mL, according to Simões et al., 2012). Column statistics were used to calculate the proportion of subjects displaying differing categories of resultant memory, referred as none, top-two biomarkers—P&F, PRNT and both. (D) Pie charts illustrated the overall resultant memory status within each category, as determined by the top-two biomarkers and PRNT. Significant differences at p<0.05 (Chi-square test) of resultant memory status amongst study groups were represented by letters “a”, b”, “c” and “d” in comparison to NV(day0), PV(day30-45), PV(year1-9) and PV(year10-11), respectively.

Article Snippet: Additional analysis was carried out employing Venn diagram ( http://bioinformatics.psb.ugent.be/webtools/Venn/ ), ROC curve (MedCalc software package, Version 7.3.0.0), heatmap (R Project for Statistical Computing Version 3.0.1) and decision tree J48 algorithm (present in WEKA software version 3.6.11).

Techniques: Functional Assay, Biomarker Discovery, Construct, Comparison